Sources | Names Used |
---|---|
CTRPv2 | BRD-K14844214 |
PharmacoGx | BRD-K14844214 |
Database | Identifier |
---|---|
Smiles: | CC(C)CC#Cc1ccc2c(O[C@@H](CN(C)C(=O)c3cnccn3)[C@H](C)CN([C@H](C)CO)S2(=O)=O)c1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GLT8D1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |
mRNA | DNAJC30 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | PRKAG1 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | BLOC1S5-TXNDC5 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
mRNA | PTRHD1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
mRNA | SLC39A8 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
mRNA | YTHDF3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
mRNA | ENTPD1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
mRNA | ABL1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
mRNA | MATR3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |